ACAD
insider transactionsACADIA PHARMACEUTICALS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-5.4K
0 buy · 5.4K sell
Net value · 30d
-$114.4K
$0 in · $114.4K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 5.4K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
-
Grant·A
-
Grant·A
-
Grant·A
Director, 10% Owner
$0
38.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
6.1K sh
Own New
-
Grant·A
Director, 10% Owner
$0
1.6K sh
Own +0%
-
Grant·A
-
Grant·A
-
Grant·A
Director
$0
9.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Exercise·M
Director
—
8.1K sh
Own +33%
-
Grant·A
Director
$0
9.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Exercise·M
Director
—
8.1K sh
Own +32%
-
Grant·A
Director
$0
9.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Exercise·M
Director
$0
2.0K sh
Own New
-
Exercise·M
Director
—
2.0K sh
Own New
-
Grant·A
Director
$0
9.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Exercise·M
Director
—
8.1K sh
Own +201%
-
Grant·A
Director
$0
9.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Exercise·M
Director
—
8.1K sh
Own +54%
-
Grant·A
Director
$0
9.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Exercise·M
Director
—
8.1K sh
Own +23%
-
Grant·A
Director, 10% Owner
$0
32.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
18.6K sh
Own +1%
-
Grant·A
-
Grant·A
-
Sell·S
PRINCIPAL ACCOUNTING OFFICER
$114.4K
5.4K sh · $21.18
Own -18%
About ACAD insider trading
This page tracks insider transactions for ACADIA PHARMACEUTICALS INC (ACAD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.